| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2025 4th Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2025 3rd Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2025 2nd Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2025 1st Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2024 4th Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2024 3rd Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2023 4th Quarter - Report |
FORBES-TATE | GENOVAC, LLC | $20,000 | |
| 2023 4th Quarter - Report |
FORBES-TATE | PELOTON INTERACTIVE, INC. | $60,000 | |
| 2023 4th Quarter - Report |
FORBES-TATE | MOLINA HEALTHCARE, INC. | $20,000 | |
| 2023 4th Quarter - Termination |
FORBES-TATE | ULTRAGENYX PHARMACEUTICAL | $40,000 |